Clinical Effectiveness of Intravitreal Therapy With Ranibizumab vs Aflibercept vs Bevacizumab for Macular Edema Secondary to Central Retinal Vein Occlusion

Hykin, Philip; Toby Prevost, A; C. Vasconcelos, Joana; Murphy, Caroline; Kelly, Joanna; Ramu, Jayashree; Hounsome, Barry; C. Yang, Yit; Harding, Simon; Lotery, Andrew; Chakravarthy, Usha; Sivaprasad, Sobha; the LEAVO Study Group, for

doi:10.1001/jamaophthalmol.2019.3305

Public

Clinical Effectiveness of Intravitreal Therapy With Ranibizumab vs Aflibercept vs Bevacizumab for Macular Edema Secondary to Central Retinal Vein Occlusion

Published in JAMA Ophthalmology • Aug 29, 2019

Authors:

Philip Hykin

A Toby Prevost

Joana C. Vasconcelos

Abstract

IMPORTANCE: The comparative clinical effectiveness of ranibizumab, aflibercept, and bevacizumab for the management of macular edema due to central retinal vein occlusion (CRVO) is unclear. OBJECTIVE: To determine whether intravitreal aflibercept or bevacizumab compared with ranibizumab results in a ...

Subject

Medicine

Ranibizumab

Aflibercept

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!